Ranked #1 in 8 out of the 10 evaluated specialties by U.S. News
MyPatients provides referring primary care providers with secure access to their patients’ information.
Boston Children's has launched the world's 1st program dedicated to offering hand transplants to children who qualify.
Innovation insider is a semi-monthly e-newsletter analyzes innovations at Boston Children’s, other academic medical centers and from industry.
Read the latest blog by a Boston Children's doctor, clinician or staff member.
Support the hospital with a donation that helps kids get the care they need.
What is leukemia?
Leukemia is blood cancer. It develops in the bone marrow—the soft, spongy center of the long bones that produces the three major blood cells:
Normal, healthy cells only reproduce when there is enough space for them to fit, and the body regulates this by sending signals so the cells know when to stop. When your child has leukemia, two things happen:
What is chronic juvenile myelomonocytic leukemia (JMML)?
JMML is, in some ways, similar to chronic myelogenous leukemia (CML), an uncommon leukemia in children. JMML is a leukemia in which the normal bone marrow production of cells becomes very disregulated. A preponderance of immature monoocytes, a type of white blood cell, is produced in the marrow. The marrow continues to produce these abnormal cells, which crowd out other healthy blood cells.
Patients with JMML are treated through Dana-Farber/Boston Children's Cancer and Blood Disorders Center, an integrated pediatric hematology and oncology partnership between Dana-Farber Cancer Institute and Boston Children’s Hospital. Visit the Dana-Farber/Boston Children's website for information on our partnership. JMML survivors receive a comprehensive follow-up evaluation from their cancer care team through the David B. Perini, Jr. Quality of Life Clinic at Dana-Farber Cancer Institute.
The future of pediatrics will be forged by thinking differently, breaking paradigms and joining together in a shared vision of tackling the toughest challenges before us.”